European Physician Survey of EGFR Inhibitor Prescribing Patterns

CompletedOBSERVATIONAL
Enrollment

453

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Metastatic Colorectal Cancer
Interventions
OTHER

Physician Survey

Eligible physicians will be contacted via telephone to perform the physician survey. A standardised questionnaire will be used to collect information about the physician's awareness of the correct indication and appropriate administration of Vectibix and the physician's experience in the administration of Vectibix treatment in the previous 6 months

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01652833 - European Physician Survey of EGFR Inhibitor Prescribing Patterns | Biotech Hunter | Biotech Hunter